Document is current
Any future updates will be listed below
-
Authors
Ohfuji, Satoko
Toyama, Nozomu
Kondo, Kyoko
Muto, Hisao
Fukushima, Wakaba
-
Funding
Funding for this research was provided by:
Grant-in-Aid for Investigation of Promotion of Health Labor Administration (24HA2007)
- License Information
-
More Information
Article History
Received: 8 May 2025
Accepted: 10 July 2025
First Online: 5 August 2025
Declarations
:
: The study protocol was conducted in accordance with the principles of the Declaration of Helsinki, and it was approved by the Ethics Committee on Medical Research at Osaka Metropolitan University (approval no. 2024-090; approval on August 9, 2024). According to the Japanese Ethical Guidelines for Medical and Biological Research Involving Human Subjects, informed consent of each patient was waived by the Ethics Committee on Medical Research at Osaka Metropolitan University (approval no. 2024-090; approval on August 9, 2024), because this study used anonymized data which was retrospectively collected from medical records at the participating clinic.
: Not applicable.
: HM had a history of employment to GSK which is a manufacture of Shingrix.
